Occupational dermatologic agents (ICD-10: L23, L24): S1 guidelines of the Working Group for Occupational and Environmental Dermatology (ABD) in the German Dermatology Society (DDG): AWMF (Association of the Scientific Medical Societies in Germany) Guidelines Registry No. 013/056;Berufliche Hautmittel (ICD-10: L23, L24): S1-Leitlinie der Arbeitsgemeinschaft für Berufs- und Umweltdermatologie (ABD) in der Deutschen Dermatologischen Gesellschaft (DDG) - AWMF-Leitlinien-Register Nr. 013/056

Arbeitsmedizin Sozialmedizin Umweltmedizin

Volumn 44, Issue 2, 2009, Pages 53-67

  Fartasch, M ^a   Diepgen, T L ^b   Drexler, H ^c   Elsner, P ^d   Fluhr, J W ^d,e   John, S M ^f   Kresken, J ^g   Wigger Alberti, W ^h  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e Bioskin   (Germany)

^f UNIVERSITY OF OSNABRÜCK   (Germany)

^g GD Gesellschaft für Dermopharmazie E V   (Germany)

^h proDERM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61349158075     PISSN: 09446052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (188)

1. Adams A, Gündel J, Strunk P, Angerer J. Zur Effektivität primärpräventiver Maßnahmen bei beruflicher PAH-Exposltion. Arbeitsmed Sozialmed Umweltmed 1999;34:97-100.
2. Agner T, Held E, West W, Gray J. Evaluation of an experimental patch test model for the detection of irritant skin reactions to moisturisers. Skin Res Technol 2000; 6(4): 250-254.
3. Allmers H. Wearing test with 2 different types of latex gloves with and without the use of a skin protection cream. Contact Dermatitis 2001; 44(1): 30-33.
4. Apfelbacher CJ, Radulescu M, Diepgen TL, Funke U. Occurrence and prognosis of hand dermatitis In the car Industry: results from the PACO follow up study (PACO II). Contact Dermatitis 2008; 58(6): 322-329.
5. Aramaki J, Effendy I, Happle R, Kawana S, Loffler C, Loffler H. Which bloenglneering assay is appropriate for Irritant patch testing with sodium lauryl sulfate? Contact Dermatitis 2001; 45(5): 286-290.
6. Baranda L, Gonzalez-Amaro R, Torres-Alvarez B, Alvarez C, Ramirez V. Correlation between pH and irritant effect of cleansers marketed for dry skin, Int J Dermatol 2002; 41(8): 494-499.
7. Bauer A, Kelterer D, Bartsch R, Pearson J, Stadeler M, Kleesz P et al. Skin protection in bakers' apprentices. Contact Dermatitis 2002; 46(2): 81-85.
8. Baur X, Chen Z, Allmers H, Raulf-Heomsoth M. Results of wearing test with two different latex gloves with and without the use of skin-protection cream, Allergy 1998; 53(4): 441-444.
9. Berardesca E. EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res Technol 1997; 3: 126-132.
10. Berardesca E, Leveque JL, Masson R EEMCO guidance for the measurement of skin microcirculation. Skin Pharmacol Appl Skin Physiol 2002; 15(6): 442-456.
11. Berndt U, Hinnen U, Iliev D, Eisner P. Hand eczema in metalworker trainees - an analysis of risk factors. Contact Dermatitis 2000; 43(6): 327-332.
12. Berndt U, Wigger-Alberti W, Gabard B, Elsner P. Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis 2000; 42(2): 77-80.
13. Berndt U, Wigger-Alberti W, Gabard B, Eisner P.Vergleich einer Hautschutzcreme und ihrer Grundlage bezüglich Wirksamkeit gegen das berufsbedingte irrltative Handekzem bei Krankenschwestern. Dermatol Beruf Umwelt 2001;49:77-80.
14. Berndt U, Gabard B, Schliemann-Willers S, Wigger-Alberti W, Zitterbart D, Eisner P. Integrated skin protection from work place irritants: a new model for efficacy assessment. Exogenous Dermatology 2002; 1:45-48.
15. BGBI. Lebensmittel-, Bedarfsgegenstände-und Futtermittelgesetzbuch. 2005.
16. Bikowski J.The use of therapeutic moisturizers in various dermatologic disorders. Cutis 2001; 68(5 Suppl): 3-11.
17. Billhimer WL, Berge CA, Englehart JS, Rains GY, Keswick BH. A modified cup scrub method for assessing the antibacterial substantivlty of personal cleansing products. J Cosmet Sci 2001; 52(6): 369-375.
18. Blichmann CW, Serup J, Winther A. Effects of single application of a moisturizer: evaporation of emulsion water, skin surface temperature, electrical conductance, electrical capacitance, and skin surface (emulsion) lipids. Acta Derm Venereol 1989; 69(4): 327-330.
19. Boman A, Mellstrom G. Percutaneous absorption of 3 organic solvents in the guinea pig. (III). Effect of barrier creams. Contact Dermatitis 1989; 21(3): 134-140.
20. Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I et al, Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007; 127(6): 1430-1435.
21. Bornkessel A, Flach M, rens-Corell M, Eisner P, Fluhr JW. Functional assessment of a washing emulsion for sensitive skin: mild impairment of stratum corneum hydration, pH, barrier function, lipid content, integrity and cohesion in a controlled washing test. Skin Res Technol 2005; 11(1): 53-60.
22. Buraczewska I, Loden M. Treatment of surfactant-damaged skin in humans with creams of different pH values. Pharmacology 2005; 73(1): 1-7.
23. Buraczewska I, Berne B, Lindberg M, Torma H, Loden M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156(3): 492-498.
24. Callard RE, Harper Jl. The skin barrier, atopic dermatitis and allergy, a role for Langerhans cells? Trends Immunol 2007; 28(7): 294-298.
25. Chilcott RP, Jenner J, Hotchkiss SA, Rice P. Evaluation of barrier creams against sulphur mustard. I. In vitro studies using human skin. Skin Pharmacol Appl Skin Physiol 2002; 15(4): 225-235.
26. Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED et al. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. Basic Clin Pharmacol Toxicol 2005; 97(1): 35-38.
27. Coenraads PJ, Diepgen TL Problems with trials and intervention studies on barrier creams and emollients at the workplace. Int Arch Occup Environ Health 2003; 76(5): 362-366.
28. Curdy C, Naik A, Kalia YN, Alberti I, Guy RH. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo. Int J Pharm 2004; 271 (1-2): 251-256.
29. Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B, Iversen L, Johansen JD et al. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol 2005; 152(1): 93-98.
30. de Fraissinette AD, Picarles V, Chibout S, Kolopp M, Medina J, Burtin P et al. Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles. Cell Biology and Toxicology 1999; 15(2): 121-135.
31. Dickel H, Bruckner T, Bernhard-Klimt C, Koch T, Scheidt R, Diepgen TL. Surveillance scheme for occupational skin disease in the Saarland, FRG. First report from BKH-S. Contact Dermatitis 2002; 46(4): 197-206.
32. Diembeck W, Beck H, Ech-Kieffer F, Courtellemont P, Dupuis J, Lovell W et al.Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic,Toiletry and Perfumery Association. Food Chem Toxicol 1999; 37(2-3): 191-205.
33. Diepgen TL, Schmidt A. Werden Inzidenzund Prävalenz berufsbedingter Hauterkrankungen unterschätzt? Arbeitsmed Sozialmed Umweltmed 2002; 37:477-480.
34. Diepgen TL, Schmidt A, Kresken J. Prävention berufsbedingter Handekzeme durch Hautschutzmaßnahmen - Ergebnisse einer betrieblichen Interventionsstudie. Arbeitsmed Sozialmed Präventivmed 2004; 39: 307-314.
35. Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Eisner P et al. Management of chronic hand eczema. Contact Dermatitis 2007; 57(4): 203-210.
36. Diepgen TL, Williams HC. Evidenzbasierte Dermatologie und die Cochrane Skin Group. Hautarzt 2005; 56:251-256.
37. Duval C, Lindberg M, Boman A, Johnsson S, Edlund F, Loden M. Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow. Skin Res Technol 2003; 9(1): 59-63.
38. El GC, Pagnoni A, Kligman AM, el GS. A model to assess the efficacy of moisturizersthe quantification of soap-induced xerosis by image analysis of adhesive-coated discs (D-Squames). Clin Exp Dermatol 1996; 21(5): 338-343.
39. Elsner P, Wigger-Alberti W, Pantini G. Perfluoropolyethers in the prevention of irritant contact dermatitis. Dermatology 1998; 197(2): 141-145.
40. EPA. EPA (Environmental Protection Agency) risk assessment forum: Guidlines for exposure assessment [FRL-4129-5]. Washington, DC: 1992.
41. EWG. Richtlinie des Rates zur Angleichung der Rechtsvorschriften der Mitgliedsstaaten über kosmetische Mittel. 76/768/EWG 1976.
42. Fartasch M, Hüner A, Tepe A, Funke U, Diepgen T. Hautphysiologische Untersuchungsmethoden in der Berufsdermatologie. Allergologie 1993; 16:25-34.
43. Fartasch M. Human barrier formation and reaction to irritation. In: Elsner P, Maibach HI, editors. Irritant dermatitis. New clinical and experimental aspects. Basel, Schweiz: Karger, 1995, S. 95-103.
44. Fartasch M. Ultrastructure of the epidermal barrier after irritation. Microsc Res Tech 1997; 37(3): 193-199.
45. Fartasch M, Schnetz E, Diepgen TL. Characterization of detergent-induced barrier alterations - effect of barrier cream on irritation. J Investig Dermatol Symp Proc 1998; 3(2): 121-127.
46. Fartasch M, Schnetz E, Ennen J, Lanzendörfer G, Diepgen TL. Charakterisierung der Barriereveränderungen durch repetitive Irritationseffekte der Barriercreme. H+G 1999; 9: 463-468.
47. Fartasch M, Deters A, Schnetz E, et al. Veränderung der Penetration durch Externa (Hautschutz): In-vivo-Erkenntnisse durch die Mikrodialyse. Dermatol Beruf Umwelt 2006; 54:80.
48. Fartasch M, Deters A, Schnetz E, Goen T, Drexler H, Schmelz M. Cutaneous penetration: its modulation by skin care products. Contact Dermatitis 2006; 55.
49. FischerT, Rystedt I. Skin protection against ionized cobalt and sodium lauryl sulphate with barrier creams. Contact Dermatitis 1983; 9(2): 125-130.
50. Fluhr JW, Kuss O, Diepgen T, Lazzerini S, Pelosi A, Gloor M et al. Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types. Br J Dermatol 2001; 145(5):696-703.
51. Fluhr JW, Akengin A, Bornkessel A, Fuchs S, Praessler J, Norgauer J et al. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol 2005; 153(1): 125-131.
52. Fowler JF, Jr. Efficacy of a skin-protective foam in the treatment of chronic hand dermatitis. Am J Contact Dermat 2000; 11 (3): 165-169.
53. Fowler JF, Jr. A skin moisturizing cream containing Quaternium-18- Bentonite effectively improves chronic hand dermatitis. J Cutan Med Surg 2001; 5(3): 201-205.
54. Frosch PJ, Kurte A. Efficacy of skin barrier creams (IV).The repetitive irritation test (RIT) with a set of 4 standard irritants. Contact Dermatitis 1994; 31 (3): 161-168.
55. Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I. Efficacy of skin barrier creams (II). Ineffectiveness of a popular "skin protector" against various irritants in the repetitive irritation test in the guinea pig. Contact Dermatitis 1993; 29(2): 74-77.
56. Frosch PJ, Peiler D, Grunert V, Grunenberg B. [Efficacy of barrier creams in comparison to skin care products in dental laboratory technicians-a controlled trial]. J Dtsch Dermatol Ges 2003; 1(7): 547-557.
57. Funke U, Fartasch M, Diepgen TL Incidence of work-related hand eczema during apprenticeship: first results of a prospective cohort study in the car industry. Contact Dermatitis 2001; 44(3): 166-172.
58. Gabard B, Schliemann-Willers S. Effizienter Hautschutz durch neue Hautschutzpräparate. SÖFW-Journal 2002; 128:2-7.
59. Gabard B, Eisner P, Treffel P. Barrier function of the skin in a repetitive irritation model and influence of 2 different treatments. Skin Res Technol 1996;2:78-82.
60. Gabard B, Chatelain E, Bieli E, Haas S. Surfactant irritation: in vitro comeosurfametry and in vivo bioengineering. Skin Res Technol 2001; 7(1): 49-55.
61. Gehring W, Geier J, Gloor M. Untersuchungen über die austrocknende Wirkung verschiedener Tenside. Dermatol Monatsschr 1991; 177:257-264.
62. Gehring W, Dördelmann C, Gloor M. Effektivitätsnachwels von Hautschutzpräparaten. Allergologie 1994; 17:97-101.
63. Gehring W, Gloor M, Kleesz P. Predictive washing test for evaluation of individual eczema risk. Contact Dermatitis 1998; 39(1): 8-13.
64. Gloor M, Wasik B, Gehring W, Grieshaber R, Kleesz P, Fluhr JW. Cleansing, dehydrating, barrier-damaging and irritating hyperaemising effect of four detergent brands: comparative studies using standardised washing models. SkiIn Res Technol 2004; 10(1): 1-9.
65. Goh C.L. Cutting oil dermatitis on guinea pig skin (I), Cutting oil dermatitis and barrier cream. Contact Dermatitis 1991 ; 24(1 ): 16-21.
66. Goh CL, Gan SL Efficacies of a barrier cream and an afterwork emollient cream against cutting fluid dermatitis in metalworkers: a prospective study. Contact Dermatitis 1994; 31(3): 176-180.
67. Goh CL, Gan SL.The Incidence of Cutting Fluid Dermatitis Among Metalworkers In A Metal Fabrication Factory - A Prospective-Study. Contact Dermatitis 1994; 31(2): 111-115.
68. Grove GL. The Effect of Moisturizers on Skin Surface Hydration As Measured Invivo by Electrical-Conductivity. Current Therapeutic Research-Clinical and Experimental 1991; 50(5): 712-719.
69. Grove GL, Zerweck CR, Heilman JM, Pyrek JD. Methods for evaluating changes In skin condition due to the effects of antimicrobial hand cleansers: two studies comparing a new waterless Chlorhexidine gluconate/ethanolemollient antiseptic preparation with a conventional water-applied product. Am J Infect Control 2001; 29(6): 361-369.
70. Grunewald AM, Gloor M, Gehring W, Kleesz P. Damage to the skin by repetitive washing. Contact Dermatitis 1995; 32(4): 225-232.
71. Gysler A, Königsmann U, Schäfer-Kortlng M, Dreidimensionale Hautmodelle zur Erfassung der perkutanen Resorption. Altex 1999; 16: 67-72.
72. Hachem JP, De Paepe K, Vanpee E, Kaufman L, Rogiers V, Roseeuw D. The effect of two molsturlsers on skin barrier damage In allergic contact dermatitis. Eur J Dermatol 2002; 12(2): 136-138.
73. Halkiersorensen L, Thestruppedersen K. The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during every-day exposure to water and detergents. Contact Dermatitis 1993; 29(5): 266-271.
74. Hannuksela A, Kinnunen T. Moisturizers prevent Irritant dermatitis. Acta Dermato-Venereologica 1992; 72(1); 42-44.
75. Held E, Agner T. Effect of moisturizers on skin susceptibility to irritants. Acta Derm Venereol 2001; 81 (2); 104-107.
76. Held E, Sveinsdottir S, Agner T. Effect of longterm use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 1999; 79(1): 49-51.
77. Held E, Lund H, Agner T. Effect of different moisturizers on SLS- Irritated human skin, Contact Dermatitis 2001 ; 44(4): 229-234.
78. Held E, Wolff C, Gyntelberg F, Agner T. Prevention of work-related skin problems In student auxiliary nurses: an intervention study. Contact Dermatitis 2001 ; 44(5); 297-303.
79. Held E, Myglnd K,Wolff C, Gyntelberg F, Agner T. Prevention of work related skin problems: an intervention study in wet work employees. Occup Environ Med 2002; 59(8): 556-561.
80. Hermann M. Nutzung von 3D- Hautmodellen zur Beurteilung der Wirksamkeit von Hautpflegeprodukten. 6. Krefelder Hautschutztag 2002.
81. Howes D, Guy R, Hadgraft J, Heylings J, Hoeck U, Kemper F et al. Methods for assessing percutaneous absorption.The report and recommendations of ECVAM workshop, ATLA 1996; 24:81-106.
82. Johnson W, Jr. Final report on the safety assessment of octoxynol-1, octoxynol-3, octoxynol-5, octoxynol-6, octoxynol-7, octoxynol8, octoxynol-9, octoxynol-10, octoxynol-11, octoxynol-12, octoxynol-13, octoxynol-16, octoxynol-20, octoxynol-25, octoxynol-30, octoxynol-33, octoxynol-40, octoxynol-70, octoxynol-9 carboxylic acid, octoxynol-20 carboxylic acid, potassium octoxynol-12 phosphate, sodium octoxynol-2 ethane sulfonate, sodium octoxynol-2 sulfate, sodium octoxynol-6 sulfate, and sodium octoxynol-9 sulfate. Int J Toxicol 2004; 23 Suppl 1:59-111.
83. Johnson W, Jr. Final report on the safety assessment of PEG-25 propylene glycol stearate, PEG-75 propylene glycol stearate, PEG-120 propylene glycol stearate, PEG-10 propylene glycol, PEG-8 propylene glycol cocoate, and PEG-55 propylene glycol oleate. Int J Toxicol 2001; 20 Suppl 4:13-26.
84. Kappes UR Goritz N, Wigger-Alberti W, Heinemann C, Eisner P.Tandem application of sodium lauryl sulfate and n-propanol does not lead to enhancement of cumulative skin irritation. Acta Derm Venereol 2001; 81 (6): 403-405.
85. Klotz A, Veeger M. Hautreinigungsmittel bei starken Verschmutzungen. Pharm Ztg 2000; 145 (35); 47-51.
86. Klotz A, Thörner B. Skin cleansers for removing heavy-dyty contamination: Testing efficacy and compatibility. SÖFW J 2002; 128:14-21,
87. Klotz A, Veeger M, Rocher W. Skin cleansers for occupational use: testing the skin compatibility of different formulations. Int Arch Occup Environ Health 2003; 76(5): 367-373.
88. Klotz A, zur Mühlen A, Thörner B, Kietzmann M, Holtmann W, Pittermann W, Testing the efficacy of skin protection products Invivo and in-vitro. SÖFW-Journal 2003; 129: 10-16.
89. Korinth G, Göen T, Kruse C, Freudlsperger F, Drexler H. Die Effektivität des persönlichen Körperschutzes zur Reduktion der inneren Belastung durch Schwefelkohlenstoff in der Viskoseindustrie. In: SchäckeG, Lüth P, editors. Arbeltsmedizin im Wandel - Bewährte Strategien und Herausforderungen. Fulda: RindtDruck, 2000:275-279.
90. Korinth G, Geh S, Schaller KH, Drexler H. In vitro evaluation of the efficacy of skin barrier creams and protective gloves on percutaneous absorption of industrial solvents. Int Arch Occup Environ Health 2003; 76(5): 382-386.
91. Korinth G, Wellner T, Luersen L, Herchenhan B, Angerer J, Drexler H. Beschleunigung der dermalen Penetration von Kühlschmierstoffen und kanzerogenen Arbeitsstoffen durch Hautschutzcremes. Arbeitsmed Sozialmed Umweltmed 2006;41(3):106.
92. Korinth G, Weiss T, Penkert S, Schaller KH, Angerer J, Drexler H. Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams. Occup Environ Med 2007; 64(6): 366-372.
93. Korinth G, Luersen L, Schaller KH, Angerer J, Drexler H. Enhancement of percutaneous penetration of aniline and o-toluldine In vitro using skin barrier creams, Toxicol In Vitro 2008; 22(3): 812-818.
94. Korstanje C, Ligtvoet FPT, Van Hemert KHF. Differential effects of dermatologlcal cream bases with respect to skin surface moisturizing capacity: a study design in volunteers. J Dermatol Treatment 1992; 2:137-139.
95. Korting HC, Hubner K, Greiner K, Hamm G, Braun-Falco O. Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol 1990; 70(5): 429-431.
96. Korting HC, Ponce-Poschl E, Klovekorn W, Schmotzer G, rens-Corell M, Braun-Falco O, The influence of the regular use of a soap or an acidic Syndet bar on pre-acne, Infection 1995; 23(2); 89-93.
97. Kresken J, Klotz A. Occupational skin-protection products- a review. Int Arch Occup Environ Health 2003; 76(5): 355-358.
98. Kresken J, Daniels R, Arens-Corell M. Dermokosmetika zur Reinigung und Pflege trockener Haut, Leitlinie der GD Gesellschaft für Dermopharmazie e.V. vom 1.10.2003, www.gd-online.de 2003.
99. Kutting B, Drexler H. Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update according to criteria of evidence-based medicine. International Archives of Occupational and Environmental Health 2003; 76(4): 253-259.
100. Lachapelle JM. Efficacy of protective creams and/or gels. Curr Probl Dermatol 1996; 25: 182-192.
101. Lademann J, Otberg N, Jacobi U, Hoffman RM, Blume-Peytavi U. Follicular penetration and targeting. J Investig Dermatol Symp Proc 2005; 10(3): 301-303.
102. Lange M, Geier J. Inhaltsstoffe von Hautschutz-, Hautreinigungs- und Hautpflegepräparaten. Eine allergologisch kommentierte Marktübersicht. Dermatol Beruf Umwelt 2005; 53:167-171.
103. Loden M.The effect of 4 barrier creams on the absorption of water, benzene, and formaldehyde into excised human skin. Contact Dermatitis 1986; 14(5): 292-296.
104. Loden M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997; 36(5): 256-260.
105. Loden M.The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 2005; 19(6): 672-688.
106. Loden M, Andersson AC. Effect of topically applied lipids on surfactant-irritated skin. Br J Dermatol 1996; 134(2): 215-220.
107. Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999; 140(2): 264-267.
108. Loden M, Andersson AC, Anderson C, Bergbrant IM, Frodin T, Ohman H et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002; 82(1): 45-47.
109. Löffler H, Effendy I. Hautschutz- oder Regenerationscreme? Der Halbseitenversuch in der Bewertung eines hautpflegenden Externums. Z Hautkr 2002; 77:234-238.
110. Marks R, Dykes PJ, Hamami I. Two novel techniques for the evaluation of barrier creams. Br J Dermatol 1989; 120(5): 655-660.
111. Mathias CG. Prevention of occupational contact dermatitis. J Am Acad Dermatol 1990; 23(4 Pt 1): 742-748.
112. McCormick RD, Buchman TL, Maki DG. Double-blind, randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers. Am J Infect Control 2000; 28(4): 302-310.
113. Meding B, Wrangsjo K, Jarvholm B. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005; 152(5): 975-980.
114. Mitchell GN. Zur Vermeidung von Hautproblemen bei Handschuhträgern im Gesundheitsdienst. Arbeitsmed Sozialmed Präventivmed 1989;24:182-183.
115. Mortz CG, Andersen KE, Halkier-Sorensen L. The efficacy of different moisturizers on barrier recovery in hairless mice evaluated by non-invasive bioengineering methods. A model to select the potentially most effective product. Contact Dermatitis 1997; 36(6): 297-301.
116. Neubert R, Wohlrab W. In vitro methods for the biopharmaceutical evaluation of topical formulations. Acta Pharm Technol 1990; 36: 197-206.
117. OECD (Organisation for Economic Co-operation and Development). OECD guidline for the testing of chemicals: Skin Absorption: in vitro methods. Paris: OECD environmental health and safety publications, 2004.
118. Olivarius FD, Hansen AB, Karlsmark T, Wulf HC. Water protective effect of barrier creams and moisturizing creams: A new in vivo test method. Contact Dermatitis 1996; 35(4): 219-225.
119. Park KS, Kim YS, Cho YH, Lee MY, Chung MS. Effects of alkalinity of household dishwashing liquids on hand skin. Contact Dermatitis 2001; 45(2): 95-98.
120. Parra JL, Paye M. EEMCO guidance for the in vivo assessment of skin surface pH. Skin Pharmacol Appl Skin Physiol 2003; 16(3): 188-202.
121. Perrenoud D, Gallezot D, van MG.The efficacy of a protective cream in a real-world apprentice hairdresser environment. Contact Dermatitis 2001; 45(3): 134-138.
122. Perrenoud D, Gogniat T, Olmstedt W. Importance of education with appropriate material for the prevention of occupational dermatitis. Dermatol Beruf Umwelt 2001; 49: 88-90.
123. Pierard GE, Goffin V, Pierard-Franchimont C. Comeosurfametry: a predictive assessment of the interaction of personal-care cleansing products with human stratum corneum. Dermatology 1994; 189(2): 152-156.
124. Plnnagoda J,Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22(3): 164-178.
125. Pittermann W, Jackwerth B, Schmitt M. The isolated perfused bovine udder skin model: A new in vitro model for the assessment of skin penetration and irritation. In Vitro Toxicology 1997;10:17-21.
126. Pittermann W, Holtmann W, Kietzmann M. Prävention gegen lipophile Noxen durch Hautschutzprodukte. Arbeitsmed Sozialmed Umweltmed 2003; 38:435-442.
127. Pittet D, Allegranzi B, Sax H, Dharan S, PessoaSilva CL, Donaldson L et al. Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis 2006; 6(10): 641-652.
128. Ponec M, Gibbs S, Pilgram G, Boelsma E, Koerten H, Bouwstra J et al. Barrier function in reconstructed epidermis and its resemblance to native human skin. Skin Pharmacology and Applied Skin Physiology 200 ; 14:63-71.
129. Pont AR, Charron AR, Brand RM. Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. Toxicol Appl Pharmacol 2004; 195(3): 348-354.
130. Ramsing DW, Agner T. Preventive and therapeutic effects of a moisturizer. An experimental study of human skin. Acta Derm Venereol 1997; 77(5): 335-337.
131. Report. Amended final report on the safety assessment of Oryza Sativa (rice) Bran Oil, Oryza Sativa (rice) Germ Oil, Rice Bran Acid,Oryza Sativa (rice) Bran Wax, Hydrogenated Rice Bran Wax, Oryza Sativa (rice)Bran Extract, Oryza Sativa (rice) Extract, Oryza Sativa (rice) Germ Powder, Oryza Sativa (rice) Starch, Oryza Sativa (rice) Bran, Hydrolyzed Rice Bran Extract, Hydrolyzed Rice Bran Protein, Hydrolyzed Rice Extract, and Hydrolyzed Rice Protein. Int J Toxicol 2006; 25 Suppl 2:91-120.
132. Report. Final report of the amended safety assessment of PEG-5, -10, -16, -25, -30, and -40 soy sterol. Int J Toxicol 2004; 23 Suppl 2:23-47.
133. Rieger T, Teichmann A, Richter H, Schanzer S, Sterry W, Lademann J. Evaluation of barrier creams - introduction and comparison of 3 in vivo methods. Contact Dermatitis 2007; 56(6): 347-354.
134. Rogiers V. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacology and Applied Skin Physiology 2001 ; 14(2): 117-128.
135. SCCNFP. Guidelines on the use of human volunteers in the testing of potentially cutaneous irritant cosmetic ingredients or mixtures of ingredients. Brussels: 1998.
136. SCCP. The SCCP's notes of guidance for the testing of cosmetic ingredients and their safety evaluation. 6th Revision ed. Brussels: 2006.
137. Schliemann S. Limitations of skin protection. Curr Probl Dermatol 2007; 34:171-177.
138. Schliemann S, Wigger-Alberti W, Eisner P. [Prevention of allergy by protective skin creams: possibilities and limits]. Schweiz Med Wochenschr 1999; 129(26): 996-1001.
139. Schliemann-Willers S, Eisner P. [Occupational skin protection] - Beruflicher Hautschutz. J Dtsch Dermatol Ges 2005; 3(2): 120-133.
140. Schmidt-Wendtner MH, Korting HC. pH and skin care. Berlin: ABW Wissenschaftsverlag, 2007.
141. Schnetz E, Fartasch M. Microdialysis for the evaluation of penetration through the human skin barrier - a promising tool for future research? European Journal of Pharmaceutical Sciences 2001; 12(3): 165-174.
142. Schnetz E, Diepgen TL, Eisner P, Frosch PJ, Klotz AJ, Kresken J et al. Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation. Contact Dermatitis 2000; 42(6): 336-343.
143. Schnuch A, Geier J, Uter W, Frosch PJ. Majantol - a new important fragrance allergen. Contact Dermatitis 2007; 57(1): 48-50.
144. Schnuch A, Uter W, Geler J, Lessmann H, Frosch PJ. Sensitization to 26 fragrances to be labelled according to current European regulation. Results of the IVDK and review of the literature. Contact Dermatitis 2007; 57(1); 1-10.
145. Serup J, Winther A, Bllchmann CW. Effects of repeated application of a moisturizer. Acta Dermato-Venereologica 1989; 69(5): 457-459.
146. Shah JH, Zhai HB, Malbach HI. Comparative evaporlmetry in man. Skin Research and Technology 2005; 11 (3): 205-208.
147. Simion FA, Rhein LD, Morrison BM, Jr., Scala DD, Salko DM, Kligman AM et al. Self-perceived sensory responses to soap and synthetic detergent bars correlate with clinical signs of irritation. J Am Acad Dermatol 1995; 32 (2 Pt 1): 205-211.
148. Soma Y, Kashlma M, Imaizuml A, Takahama H, Kawakami T, Mizoguchi M. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 2005; 44(3): 197-202.
149. Speiser-Rankine N, Unterberger W, Taibi R, Payer-Neulinger G, Mittlböck M, Strohal R. Development and inplementation of process-oriented skin safety standards for the mineral oil industry: A pilot study. 8th SPE International Conference on Health, Safety and Environment in Oil and Gas Exploration and Production 2006; 2:853-863.
150. Spoo J, Wlgger-Alberti W, Berndt U, Fischer T, Eisner P. Skin cleansers: three test protocols for the assessment of irritancy ranking. Acta Derm Venereol 2002; 82(1): 13-17.
151. Suskind RR. Industrial and Laboratory Evaluation of A Silicone Protective Cream. Ama Archives of Industrial Hygiene and Occupational Medicine 1954; 9(2): 101-112.
152. Teichmann A, Jacobi U, Walbler E, Sterry W, Lademann J, An In vivo model to evaluate the efficacy of barrier creams on the level of skin penetration of chemicals. Contact Dermatitis 2006; 54(1): 5-13.
153. Treffel P, Gabard B. Stratum-corneum dynamic function measurements after moisturizer or irritant application. Archives of Dermatological Research 1995; 287(5): 474-479.
154. Treffel P, Gabard B, Juch R. Evaluation of Barrier Creams - An In-VitroTechnique on Human Skin. Acta Dermato-Venereologlca 1994; 74(1): 7-11.
155. Tronnier H. Über Hautschutzsalben. 1. Mitteilung: Untersuchungen über die Diffusion von Schadstoffen durch Hautschutzsalben. Berufsdermatosen 1964; 12:241-281.
156. Tronnier H. Methodische Ansätze zur Prüfung von Hautschutzmitteln. Dermatosen 1993;41: 100-107.
157. Tronnier H, Kresken J, Jackwerth B, Komp B. Haut und Beruf - Strategien zur Verhütung berufsbedingter Hauterkrankungen, Berlin: Grosse Verlag, 1989.
158. Tupker RA, Willis C, Berardesca E, Lee CH, Fartasch M, Agner T et al. Guidelines on sodium lauryl sulfate (SLS) exposure tests - A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997; 37(2): 53-69.
159. Ursin C, Hansen CM, Vandyk JW, Jensen PO, Christensen IJ, Ebbehoej J. Permeability of Commercial Solvents Through Living Human Skin. American Industrial Hygiene Association Journal 1995; 56(7): 651-660.
160. Uter W, Geier J, Lessmann H, Schnuch A. Inhaltsstoffe von Hautschutz- und Pflegemitteln aus allergologlscher Sicht. Analyse von IVDK-Daten und Literaturübersicht. Dermatol Beruf Umwelt 2005; 53:172-182.
161. Van de Sandt JR, Roguet C, Cohen D, Esdaile M, Ponec M, Corslnl E et al. The use of human keratinocytes and human skin models for predicting skin irritation. The report and recommendation of ECVAM (Europäisches Zentrum für die Validierung von Alternativmethoden) 38th workshop "Alternatives to lavoratory animals" 1999; 27:723-743.
162. van der Bijl P, Gareis A, Lee H, van Eyk AD, Stander IA, Cilliers J. Effects of two barrier creams on the diffusion of benzo[a]pyrene across human skin, SADJ 2002; 57(2): 49-52.
163. Weisshaar E, Radulescu M, Bock M, Albrecht U, Diepgen TL. Educational and dermatological aspects of secondary individual prevention in healthcare workers. Contact Dermatitis 2006; 54(5): 254-260.
164. Weisshaar E, Kirschner F, Zimmermann E, Bruckner T, Gottfreund J, Meyer T et al. Sebamed Hand Repair Balsam bei Patienten mit chronischem Handekzem: Ergebnisse einer Anwendungsbeobachtung, Dermatol Beruf Umwelt 2007; 55:60-66.
165. Welsshaar E, Radulescu M, Soder S, Apfelbacher CJ, Bock M, Grundmann JU et al. Secondary individual prevention of occupational skin diseases in health care workers, cleaners and kitchen employees: alms, experiences and descriptive results. Int Arch Occup Environ Health 2007; 80(6): 477-484.
166. Wellner T, Göen T, Drexler H, Systemische Therapie durch dermale Applikation: Transdermale Therapeutische Systeme. Dermatol Beruf Umwelt 2006; 54:13-18.
167. Wigger-Alberti W. Möglichkeiten und Grenzen von Hautschutzmitteln, Dermatol Beruf Umwelt 2005; 53:158-166.
168. Wigger-Alberti W, Eisner P. Preventive measures in contact dermatitis. Clin Dermatol 1997; 15(4): 661-665.
169. Wigger-Alberti W, Eisner P. Barrier creams and emollients. In: Kanerva L, Eisner P, Wahlberg JE, Maibach H, editors. Handbook of Occupational Dermatology. Berlin: Springer, 2000, S. 490-496.
170. Wigger-Alberti W, Maraffio B, Wernli M, Elsner P.Training workers at risk for occupational contact dermatitis in the application of protective creams: efficacy of a fluorescence technique. Dermatology 1997; 195(2): 129-133.
171. Wigger-Alberti W, Rougier A, Richard A, Elsner P. Efficacy of protective creams In a modified repeated Irritation test. Methodological aspects. Acta Derm Venereol 1998; 78(4): 270-273,
172. Wigger-Alberti W, Fischer T, Greif C, Maddern P, Elsner P. Effects of various grit-containing cleansers on skin barrier function. Contact Dermatitis 1999;41(3): 136-140.
173. Wlgger-Alberti W, Caduff L, Burg G, Eisner P. Experimentally Induced
174. Wigger-Alberti W, Spoo J, Schllemann-Willers S, Klotz A, Eisner P.The tandem repeated Irritation test: a new method to assess prevention of irritant combination damage to the skin. Acta Derm Venereol 2002; 82(2): 94-97.
175. Wigger-Alberti W, Diepgen T, Elsner P, Korting HC, Kresken J, Schwanitz HJ. Berufliche Hautschutzmittel, Gemeinsame Leitlinie der Arbeitsgemeinschaft für Berufs- und Umweltdermatologie (ABD) in der Deutschen Dermatologischen Gesellschaft (DDG) und der Gesellschaft für Dermopharmazie e.V. (GD). Dermatol Beruf Umwelt 2003; 51: 15-21.
176. Williams FM. In vitro studies - how good are they at replacing in vivo studies for measurement of skin absorption? Environmental Toxicology and Pharmacology 2006; 21(2); 199-203.
177. Willis CM, Stephens CJ, Wilkinson JD. Epidermal damage Induced by Irritants in man: a light and electron microscopic study. J Invest Dermatol 1989; 93(5): 695-699,
178. Willis CM, Stephens CJ, Wilkinson JD. Selective expression of immune-associated surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol 1991; 96(4): 505-511.
179. Willis CM, Stephens CJ, Wilkinson JD. Differential effects of structurally unrelated chemical irritants on the density of proliferating keratinocytes in 48 h patch test reactions. J Invest Dermatol 1992; 99(4): 449-453.
180. Willis CM, Stephens CJ, Wilkinson JD. Differential patterns of epidermal leukocyte Infiltration in patch test reactions to structurally unrelated chemical irrltants. J Invest Dermatol 1993; 101 (3):364-370.
181. Wilmer JL, Burleson FG, Kayama F, Kanno J, Luster MI. Cytokine induction In human epidermal-keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. Journal of Investigative Dermatology 1994; 102(6): 915-922.
182. Wulfhorst B, Bock M, Skudlik C, John SM. Worker education and teaching Programs: The German experience. In: Frosch PJ, Menne T, Lepoittevin J, editors. Textbook of contact dermatitis. Berlin, Heidelberg, NewYork: 2006: 855-861.
183. Zachariae C, Held E, Johansen JD, Menne T, Agner T. Effect of a moisturizer on skin susceptibility to NICl2. Acta Derm Venereol 2003; 83(2): 93-97.
184. Zhai H, Willard P, Maibach HI. Evaluating skin-protective materials against contact irritants and allergens. An in vivo screening human model. Contact Dermatitis 1998; 38(3): 155-158.
185. Zhai H, Schmidt R, Levin C, Klotz A, Maibach HI. Prevention and therapeutical effects of a model emulsion on glove-induced irritation and dry skin In man. Dermatol Beruf Umwelt 2001;50:134-138.
186. zur Mühlen A, Klotz A, Weimans S, Veeger M, Thorner B, Diener B et al. Using skin models to assess the effects of a protection cream on skin barrier function. Skin Pharmacol Physiol 2004; 17(4): 167-175.
187. zur Mühlen A, Klotz A, Veeger M, Thörner B, Welmans S, Eichler JO et al. Untersuchung des biochemischen Wirkmechanismus einer Hautpflegeformullerung unter Nutzung eines 3D-Hautmodells. Arbeitsmed Sozialmed Umweltmed 2005; 40:392-397.
188. zur Mühlen A, Klotz A, Allef P, Welmans S, Veeger M, Thorner B et al. Using skin models to assess the effects of a pre-work cream. Curr Probl Dermatol 2007; 34:19-32.